跳至主要内容
分组视图 1739 条记录 · 页 32/35

化妆品禁用物质 — 附件 II

附件 II 列出了禁止作为化妆品成分有意添加的物质。第 17 条另行规定了在良好生产规范和第 3 条安全要求下技术上不可避免的非有意微量存在的情形。本页包含 1739 条记录。

筛选此附件

本附件的作用方式

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

核对依据

附件 II 记录

1739 共
本列表中的记录,共 1739 条
条目物质CAS最大浓度标记
1578ParaformaldehydeCAS 30525-89-4 30525-89-4 —CMR
1579Methanediolmethylene glycolCAS 463-57-0 463-57-0 —
1580cymoxanil (ISO)2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [1]/ (2E)-2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide; [2]CAS 57966-95-7 / 166900-80-7 57966-95-7 / 166900-80-7 —CMR
1581Tributyltin compounds——CMR
1582Tembotrione (ISO)2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dioneCAS 335104-84-2 335104-84-2 —CMR
15831,2-Benzenedicarboxylic acid, dihexyl ester, branched and linearCAS 68515-50-4 68515-50-4 —CMR
1584Spirotetramat (ISO)(5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonateCAS 203313-25-1 203313-25-1 —CMR
1585Dodemorph acetate4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetateCAS 31717-87-0 31717-87-0 —CMR
1586Triflusulfuron-methylmethyl 2-({[4-(dimethylamino)-6-(2,2,2- trifluoroethoxy)-1,3,5-triazin-2- yl]carbamoyl}sulfamoyl)-3- methylbenzoateCAS 126535-15-7 126535-15-7 —CMR
1587Imazalil (ISO)1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazoleCAS 35554-44-0 35554-44-0 —CMR
1588Dodemorph (ISO)4-cyclododecyl-2,6-dimethylmorpholineCAS 1593-77-7 1593-77-7 —CMR
1589ImidazoleCAS 288-32-4 288-32-4 —CMR
1590Lenacil (ISO)3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dioneCAS 2164-08-1 2164-08-1 —CMR
1591Metosulam (ISO)N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamideCAS 139528-85-1 139528-85-1 —CMR
15922-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-oneCAS 71868-10-5 71868-10-5 —CMR
15932,3-Epoxypropyl methacrylateglycidyl methacrylateCAS 106-91-2 106-91-2 —CMR
1594Spiroxamine (ISO)8-tert-butyl-1,4-dioxaspirol[4.5]decan-2-ylmethyl(ethyl)(propyl)amineCAS 118134-30-8 118134-30-8 —CMR
1595CyanamidecarbanonitrilCAS 420-04-2 420-04-2 —CMR
1596Cyproconazole (ISO)(2RS,3RS; 2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-olCAS 94361-06-5 94361-06-5 —CMR
1597Silver zinc zeoliteCAS 130328-20-0 130328-20-0 —CMR
1598Cadmium carbonateCAS 513-78-0 513-78-0 —CMR
1599Cadmium hydroxidecadmium dihydroxideCAS 21041-95-2 21041-95-2 —CMR
1600Cadmium nitratecadmium dinitrateCAS 10325-94-7 10325-94-7 —CMR
1601Dibutyltin dilauratedibutyl[bis(dodecanoyloxy)] stannaneCAS 77-58-7 77-58-7 —CMR
1602Clorofenechlorophene; 2-benzyl-4-chlorophenolCAS 120-32-1 120-32-1 —CMR
1603Anthraquinone9,10-anthraquinoneCAS 84-65-1 84-65-1 —CMR
1604Nonadecafluorodecanoic acid [1]Ammonium nonadecafluorodecanoate [2]; Sodium nonadecafluorodecanoate [3]CAS 335-76-2[1] 3108-42-7[2] 3830-45-3[3] 335-76-2[1] 3108-42-7[2] 3830-45-3[3] —CMR
1605N,N'-MethylenedimorpholineN,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/wCAS 5625-90-1 5625-90-1 —CMR
1606Reaction products of paraformaldehyde with 2-hydroxypropylamine (3:2)[formaldehyde released from 3,3'-methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w——
1607Reaction products of paraformaldehyde with 2-hydroxypropylamine (1:1))[formaldehyde released from a,a,a-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is = 0,1 % w/w——
1608MethylhydrazineCAS 60-34-4 60-34-4 —CMR
1609Triadimenol (ISO)(1RS,2RS; 1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; a-tert-butyl-ß-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanolCAS 55219-65-3 55219-65-3 —CMR
1610Thiacloprid (ISO)(Z)-3-(6-chloro-3-pyridyl-methyl)-1-3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamideCAS 111988-49-9 111988-49-9 —CMR
1611Carbetamide (ISO)(R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)-1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamateCAS 16118-49-3 16118-49-3 —CMR
1612Phosmet (ISO)S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioateCAS 732-11-6 732-11-6 —CMR
1613Potassium permanganateCAS 7722-64-7 7722-64-7 —CMR
16142-Benzyl-2-dimethylamino-4'- morpholinobutyrophenoneCAS 119313-12-1 119313-12-1 —CMR
1615Quizalofop-p-tefuryl (ISO)(+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionateCAS 200509-41-7 200509-41-7 —CMR
1616Propiconazole (ISO)(2RS,4RS; 2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazoleCAS 60207-90-1 60207-90-1 —CMR
1617Pinoxaden (ISO)8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoateCAS 243973-20-8 243973-20-8 —CMR
1618Tetramethrin(1-Cyclohexene-1,2-Dicarboximido)Methyl Chrysanthemate; 2,2-Dimethyl-3-(2-Methyl-1-Propenyl)Cyclopropanecarboxylic Acid (1,3,4,5,6,7-Hexahydro-1,3-Dioxo-2H-Isoindol-2-yl)Methyl EsterCAS 7696-12-0 7696-12-0 —CMR
1619(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylateCAS 1166-46-7 1166-46-7 —CMR
1620Spirodiclofen (ISO)3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrateCAS 148477-71-8 148477-71-8 —CMR
1621Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamineCAS 897393-42-9 897393-42-9 —CMR
16221-VinylimidazoleCAS 1072-63-5 1072-63-5 —CMR
1623Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamideCAS 348635-87-0 348635-87-0 —CMR
1624Pirimicarb (ISO)2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamateCAS 23103-98-2 23103-98-2 —CMR
16251,2-Dichloropropanepropylene dichlorideCAS 78-87-5 78-87-5 —CMR
1626Phenol, dodecyl-, branched [1]Phenol, 2-dodecyl-, branched [2]; Phenol, 3-dodecyl-, branched [3]; Phenol, 4-dodecyl-, branched [4]; Phenol, (tetrapropenyl) derivatives [5]CAS 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] 121158-58-5[1]; 1801269-80-6[2] ; 1801269-77-1[3]; 210555-94-5[4]; 74499-35-7[5] —
1627Coumatetralyl (ISO)4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarinCAS 5836-29-3 5836-29-3 —CMR

如何使用此分组视图

附件 II 包含化妆品禁用物质。当您想按名称、标识符和关联条目页面快速浏览 1739 条禁用物质记录时,请使用此分组视图。

当您需要完整的法律措辞、浓度逻辑、警示语或相关标识符的交叉链接时,请打开单条记录。